Almirall prints debut €250m convertible bond
Almirall, the Spanish pharmaceuticals company, has issued its first convertible bond with an equity-neutral structure, having attracted “strong outright demand” from institutional investors, according to a banker on the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts